AOLS - Aeolus Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5121.67k
Enterprise Value 3-281.33k
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.16
Price/Book (mrq)0.80
Enterprise Value/Revenue 3-0.37
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 3.73
52-Week Change 3-72.50%
S&P500 52-Week Change 3-0.33%
52 Week High 30.0060
52 Week Low 30.0008
50-Day Moving Average 30.0013
200-Day Moving Average 30.0016

Share Statistics

Avg Vol (3 month) 393.44k
Avg Vol (10 day) 380.46k
Shares Outstanding 5152.09M
Float 47.04M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Oct 10, 2002) 4N/A
Short Ratio (Oct 10, 2002) 45.53
Short % of Float (Oct 10, 2002) 4N/A
Short % of Shares Outstanding (Oct 10, 2002) 40.00%
Shares Short (prior month Aug 12, 2002) 41.05k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jul 16, 2004

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2016
Most Recent Quarter (mrq)Jun 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-531.00%

Management Effectiveness

Return on Assets (ttm)-90.30%
Return on Equity (ttm)-186.43%

Income Statement

Revenue (ttm)771k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-98.00%
Gross Profit (ttm)-805k
EBITDA N/A
Net Income Avi to Common (ttm)-4.09M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)403k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.30
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-3.35M
Levered Free Cash Flow (ttm)-1.81M